13-29025692-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001033602.4(MTUS2):c.994C>T(p.Leu332=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00373 in 1,613,980 control chromosomes in the GnomAD database, including 193 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.020 ( 97 hom., cov: 32)
Exomes 𝑓: 0.0020 ( 96 hom. )
Consequence
MTUS2
NM_001033602.4 synonymous
NM_001033602.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.706
Genes affected
MTUS2 (HGNC:20595): (microtubule associated scaffold protein 2) Enables microtubule binding activity and protein homodimerization activity. Part of nucleus. Colocalizes with centrosome and cytoplasmic microtubule. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 13-29025692-C-T is Benign according to our data. Variant chr13-29025692-C-T is described in ClinVar as [Benign]. Clinvar id is 790671.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.706 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0656 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTUS2 | NM_001033602.4 | c.994C>T | p.Leu332= | synonymous_variant | 3/16 | ENST00000612955.6 | NP_001028774.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTUS2 | ENST00000612955.6 | c.994C>T | p.Leu332= | synonymous_variant | 3/16 | 5 | NM_001033602.4 | ENSP00000483729 |
Frequencies
GnomAD3 genomes AF: 0.0199 AC: 3024AN: 152178Hom.: 95 Cov.: 32
GnomAD3 genomes
AF:
AC:
3024
AN:
152178
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00520 AC: 1293AN: 248680Hom.: 41 AF XY: 0.00398 AC XY: 537AN XY: 134946
GnomAD3 exomes
AF:
AC:
1293
AN:
248680
Hom.:
AF XY:
AC XY:
537
AN XY:
134946
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00205 AC: 2994AN: 1461684Hom.: 96 Cov.: 31 AF XY: 0.00175 AC XY: 1272AN XY: 727120
GnomAD4 exome
AF:
AC:
2994
AN:
1461684
Hom.:
Cov.:
31
AF XY:
AC XY:
1272
AN XY:
727120
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0199 AC: 3033AN: 152296Hom.: 97 Cov.: 32 AF XY: 0.0193 AC XY: 1434AN XY: 74474
GnomAD4 genome
AF:
AC:
3033
AN:
152296
Hom.:
Cov.:
32
AF XY:
AC XY:
1434
AN XY:
74474
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
16
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at